A PROMISING NEW DEVICE FOR DIABETICS

Thursday, Jan. 19, 1995
  • Share
  • Read Later
The Pfizer company and Inhale Therapeutic Systems announced that they are collaborating on a device that will allow diabetes patients to inhale insulin rather than inject the drug. Of the more than 14 million Americans who have diabetes, some 500,000 must take insulin every day. Inhale said it has completed the first phase of clinical trials on the product and that Pfizer expects to start trials on people later this year.